David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), bought 2,500 shares at $11.05 ($28K) on 2019-05-31, disclosed to the SEC on 2019-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |